← Back
Data updated: Mar 10, 2026
TRIPOINT
Pharmaceuticals
TRIPOINT is a pharmaceutical company with 1 FDA-approved products.
2018
Since
1
Drugs
-
Trials
1
Approved (2yr)
Key Drugs
No active drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (0)
Discontinued (1)
Company Info
- First Approval
- 2018-12-20
- Latest
- 2024-03-12
- Applications
- 1